Close Icon

Pharmacovigilance & Epidemiology Team Solutions

Put the Power of Active Safety Surveillance in Your Clients’ Hands.
Active Safety Analytics for Pharma (ASAP)

Key Takeaway

While voluntary adverse event reports are vital tools for ensuring safety after drugs go to market, the FDA’s active surveillance approach through the Sentinel System is much more powerful. Saama gives pharma the same real-world data analytics capabilities in order to be more proactive about safety.

  • Identify outcomes associated with different drugs
  • Understand the safety profiles of competitive products
  • Explore potential causal relationships between drug/outcome pairs
  • Respond rapidly and comprehensively to regulatory requests and potential findings
Request a Demo
 

Active Safety Analytics for Pharma (ASAP)

Help the sponsors you work with identify new and unexpected safety signals using real-world data (RWD)—healthcare claims and electronic medical records (EMR)—to find associations between their drugs and specific adverse outcomes. ASAP leverages an advanced statistical (TreeSCan) methodology to unlock specific safety signals from billions of records in the health profiles of millions of patients.

  • Initiate safety analysis by defining study design parameters
  • Review TreeScan alerts and drill down to individual patients
  • Assess TreeScan alerts and route for review and approval
  • Review reports comparing TreeScan alerts across multiple analyses
Learn More

Get Started Today

To arrange a demo and learn more about how you can set up ASAP as a secure subscription service in the cloud, contact us!

Contact Us

Terms & Conditions

By inquiring about Saama’s Database Lock in a Day, you agree to be contacted by Saama and to allow Saama to use, maintain, store, and protect your personal data in accordance with our Privacy Policy.

Eligibility details are for informational purposes only. Saama, in its sole discretion, will determine your eligibility based on the information you disclose as part of the intake process. If Saama determines that you are eligible to participate, you will be notified by separate email. Eligibility depends on certain criteria, such as the size of your company, the types of clinical trials you sponsor, and the number of patients in–and stages of–your current clinical trials.

By completing the request form, you represent that you have authority to proceed on behalf of your company. Should you agree to participate, you agree to reasonably cooperate with Saama in following the guidelines and procedures required for integrating, standardizing, and analyzing your data. Participation requires the use of our Smart Data Quality application, a technology-agnostic AI engine that sits on top of your current infrastructure. The application can be used immediately, and you’re only charged for the services you use based on a predetermined estimate.

Information you share with Saama during your participation may be anonymized and/or aggregated, and made available publicly in Saama marketing materials. This information may include: types of systems and processes involved, types of departments involved, and size and regional location of your company. Such information will never be directly associated with you, nor will you or your company be identifiable without express written permission.